Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech News -- Ignore unavailable to you. Want to Upgrade?

To: zeta1961 who wrote (4634)	4/4/2006 1:49:21 PM
From: nigel bates	Read Replies (2) \| Respond to of 7143

Sounds really cool stuff (company is private I think, so nothing from an investment perspective). Even if it's only a subset, anything which works for CF would be more than welcome. ...nonsense mutations are the cause of CF in approximately 10% of patients in the United States.

To: zeta1961 who wrote (4634)	4/4/2006 2:03:06 PM
From: zeta1961	Respond to of 7143

Thanks..musta' been at JPMorgan..my fave patient of my entire career died in London, awaiting a lung transplant in 1990..just a coupla' years too sick..she went kicking; taking on the entire Harvard system with her activism..her friends at Harvard Crimson got print in the NYT after her death..I was called to my supervisor for sneaking her out of the hospital to get a lead on a story downtown..reason?..her doc looked the other way while a fellow nurses wimped out on the 'conspiracy.' Life is very interesting..